24/7
Buzz
Startups
VC
AI
Innovation
Opinions
Events
Promising Startups 2024
BiblioTech
Boarding Pass
Corporate
Appointments
CTalk
Tech Gateways
2025 VC survey
@Finance
Ctech Testimonials
Shopping
Projects
Spotlight
About
Newsletter
Contact us
Facebook
Twitter
ACCESSIBILITY
by
Homepage
Arkin
Tags search
HOME
24/7
buzz
STARTUPS
VC
AI
Innovation
OPINIONS
EVENTS
Projects
ABOUT
teram of use
Privacy Policy
NEWSLETTER
SEARCH
CONTACT US
ACCESSIBILITY
24/7
Headlines
09:40
The layoffs sweeping Israeli tech may only be the beginning
00:17
SentinelOne shares tumble after layoffs and weak forecast overshadow earnings
21:48
Anthropic closes colossal $65 billion funding round at $900 billion valuation
20:26
Black Thursday: Israeli tech reels as Wix, Amdocs, Rapyd and SentinelOne cut jobs
More stories
Buzz
Most popular
Daily
Weekly
1
Cyber firm SentinelOne set to lay off hundreds of employees
2
Israel’s Iron Beam laser system sits idle despite war: “Appropriate, professional steps are being taken”
3
Thousands of foreign workers caught in collapse of Israeli money transfer company
4
Israeli ministries join opposition to $4.2 billion Zim-Hapag deal
5
Wix CEO to employees: “I won’t pretend that we’re not looking at potential changes”
More news
Arkin
2 stories about Arkin
Arkin raises $100 million biotech fund focused on early clinical science
12.01.26
|
CTech
Arkin Bio Ventures III emphasizes scientific rigor amid shifting biotech markets.
Censa Pharmaceuticals Signs Joint Development Agreement with Biotech Company Retrophin
07.01.18
|
Lilach Baumer
Censa, a company developing treatments for orphan metabolic diseases, is a portfolio company of Israel-based Arkin Bio Ventures